NCT01507857View on ClinicalTrials.gov

An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

10,077

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Hand, Foot and Mouth Disease
Interventions
BIOLOGICAL

400U /0.5ml EV71 vaccine

inactivated vaccine (vero cell) against EV71 of 400U /0.5ml, two doses, 28 days interval

BIOLOGICAL

0/0.5ml placebo

0/0.5ml placebo, two doses, 28 days interval

Trial Locations (3)

Unknown

Ganyu, Lianyungang

Taixing, Taizhou

Sheyang CDC, Yancheng

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT01507857 - An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine | Biotech Hunter | Biotech Hunter